Document Detail


Medicinal Chemistry - XXth International Symposium.
MedLine Citation:
PMID:  18988115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The XXth International Symposium on Medicinal Chemistry (EFMC-ISMC 2008) was organized by the Austrian Chemical Society on behalf of the European Federation for Medicinal Chemistry (EFMC). Approximately 1400 scientists from 58 nations congregated over the course of the event to discuss the latest advances in the fields of neurodegenerative diseases, antipsychotics, pain, diabetes, COPD and asthma, immunology, antivirals and oncology. The agenda included plenary and award lectures, oral sessions, and over 600 poster presentations.
Authors:
Jane Watt; Gemma Sutton
Related Documents :
11760975 - Predicting performance on the royal college of physicians and surgeons of canada intern...
11499455 - Research validity scales for the neo-pi-r: additional evidence for reliability and vali...
2297285 - Training and practice activities of hematology and medical oncology diplomates.
8921565 - Odor aversion of multiple chemical sensitivities: recommendation for a name change and ...
17432775 - Management of the anxious patient: what treatments are available?
15706175 - Occupational contribution to the burden of chronic obstructive pulmonary disease.
Publication Detail:
Type:  Congresses    
Journal Detail:
Title:  IDrugs : the investigational drugs journal     Volume:  11     ISSN:  1369-7056     ISO Abbreviation:  IDrugs     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-06     Completed Date:  2008-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883655     Medline TA:  IDrugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  771-3     Citation Subset:  IM    
Affiliation:
Thomson Reuters, Suite 3/1, 3rd Floor, Skypark SP1, Elliot Place, Glasgow, G38EP, UK. jane.watt@thomsonreuters.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / antagonists & inhibitors
Analgesics
Angiogenesis Inhibitors / pharmacology
Animals
Anti-HIV Agents / pharmacology
Antineoplastic Agents / pharmacology
Biological Products
Chemistry, Pharmaceutical / trends*
HSP90 Heat-Shock Proteins / antagonists & inhibitors
Humans
Pain / drug therapy
Polymers
Chemical
Reg. No./Substance:
0/Analgesics; 0/Angiogenesis Inhibitors; 0/Anti-HIV Agents; 0/Antineoplastic Agents; 0/Biological Products; 0/HSP90 Heat-Shock Proteins; 0/Polymers; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An application of artificial neural network models to estimate air temperature data in areas with sp...
Next Document:  Advances in cancer drug discovery - a British association for cancer research meeting.